215 related articles for article (PubMed ID: 31421859)
1. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory 2B4 contributes to NK cell education and immunological derangements in XLP1 patients.
Meazza R; Falco M; Marcenaro S; Loiacono F; Canevali P; Bellora F; Tuberosa C; Locatelli F; Micalizzi C; Moretta A; Mingari MC; Moretta L; Aricò M; Bottino C; Pende D
Eur J Immunol; 2017 Jun; 47(6):1051-1061. PubMed ID: 28386908
[TBL] [Abstract][Full Text] [Related]
3. Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor.
Martínez-Vicente P; Farré D; Sánchez C; Alcamí A; Engel P; Angulo A
PLoS Pathog; 2019 Apr; 15(4):e1007658. PubMed ID: 30947296
[TBL] [Abstract][Full Text] [Related]
4. 2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.
Mou J; Xie L; Xu Y; Zhou T; Liu Y; Huang Q; Tang K; Tian Z; Xing H; Qiu S; Rao Q; Wang M; Wang J
Cytotherapy; 2023 Oct; 25(10):1080-1090. PubMed ID: 37516949
[TBL] [Abstract][Full Text] [Related]
5. A Developed NK-92MI Cell Line with Siglec-7
Huang CH; Liao YJ; Fan TH; Chiou TJ; Lin YH; Twu YC
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29617289
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia immune escape by epigenetic CD48 silencing.
Wang Z; Xiao Y; Guan W; Wang M; Chen J; Zhang L; Li Y; Xiong Q; Wang H; Wang M; Li Y; Lv N; Li Y; Wang L; Yu L
Clin Sci (Lond); 2020 Jan; 134(2):261-271. PubMed ID: 31922199
[TBL] [Abstract][Full Text] [Related]
7. Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody.
Lee HR; Son CH; Koh EK; Bae JH; Kang CD; Yang K; Park YS
Sci Rep; 2017 Sep; 7(1):11075. PubMed ID: 28894091
[TBL] [Abstract][Full Text] [Related]
8. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
Lee JC; Lee KM; Kim DW; Heo DS
J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
[TBL] [Abstract][Full Text] [Related]
9. CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells.
Messmer B; Eissmann P; Stark S; Watzl C
J Immunol; 2006 Apr; 176(8):4646-50. PubMed ID: 16585556
[TBL] [Abstract][Full Text] [Related]
10. Branched I antigens on leukemia cells enhanced sensitivity against natural killer-cell cytotoxicity through affecting the target-effector interaction.
Lee YH; Liao YJ; Huang CH; Chang FL; Fan TH; Twu YC
Transfusion; 2017 Apr; 57(4):1040-1051. PubMed ID: 28337749
[TBL] [Abstract][Full Text] [Related]
11. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
13. Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells.
Kim EO; Kim N; Kim TJ; Kim K; Kim TW; Kumar V; Lee KM
J Leukoc Biol; 2010 Oct; 88(4):707-14. PubMed ID: 20647560
[TBL] [Abstract][Full Text] [Related]
14. The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells.
Betser-Cohen G; Mizrahi S; Elboim M; Alsheich-Bartok O; Mandelboim O
J Immunol; 2010 Mar; 184(6):2761-8. PubMed ID: 20164429
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the human 2B4 (CD244)/CD48 interaction: Lys68 and Glu70 in the V domain of 2B4 are critical for CD48 binding and functional activation of NK cells.
Mathew SO; Kumaresan PR; Lee JK; Huynh VT; Mathew PA
J Immunol; 2005 Jul; 175(2):1005-13. PubMed ID: 16002700
[TBL] [Abstract][Full Text] [Related]
16. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas.
Chiba M; Shimono J; Ishio T; Takei N; Kasahara K; Ogasawara R; Ara T; Goto H; Izumiyama K; Otsuguro S; Perera LP; Hasegawa H; Maeda M; Hashino S; Maenaka K; Teshima T; Waldmann TA; Yang Y; Nakagawa M
Blood; 2022 Nov; 140(18):1951-1963. PubMed ID: 35921533
[TBL] [Abstract][Full Text] [Related]
18. SHIP influences signals from CD48 and MHC class I ligands that regulate NK cell homeostasis, effector function, and repertoire formation.
Fortenbery NR; Paraiso KH; Taniguchi M; Brooks C; Ibrahim L; Kerr WG
J Immunol; 2010 May; 184(9):5065-74. PubMed ID: 20363967
[TBL] [Abstract][Full Text] [Related]
19. M2-polarized and tumor-associated macrophages alter NK cell phenotype and function in a contact-dependent manner.
Krneta T; Gillgrass A; Poznanski S; Chew M; Lee AJ; Kolb M; Ashkar AA
J Leukoc Biol; 2017 Jan; 101(1):285-295. PubMed ID: 27493241
[TBL] [Abstract][Full Text] [Related]
20. Functional role of human NK cell receptor 2B4 (CD244) isoforms.
Mathew SO; Rao KK; Kim JR; Bambard ND; Mathew PA
Eur J Immunol; 2009 Jun; 39(6):1632-41. PubMed ID: 19499526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
